Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002)

Eiji Oki, Yasunori Emi, Yuji Miyamoto, Akira Kabashima, Hidefumi Higashi, Yutaka Ogata, Masahiko Ikebe, Hiroshi Saeki, Shoji Tokunaga, Ken Shirabe, Toru Beppu, Shinji Uchida, Mitsuhisa Takatsuki, Masahiko Sakoda, Susumu Eguchi, Yoshito Akagi, Yoshihiro Kakeji, Hideo Baba, Shoji Natsugoe, Yoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002)'. Together they form a unique fingerprint.

Medicine & Life Sciences